To conclude, we identified two distinct qPCR gene expression profiles correlating with response (low expression of ALDH6A1 + TFF2 + MCM5) and with PFS (KLF12-high + TFF2-low) in advanced colon cancer patients managed with bevacizumab and chemotherapy. This evidence concerns the gene ALDH6A1 and malignant colon neoplasm.